MRNA
NASDAQ · Biotechnology
Moderna Inc
$54.35
+5.81 (+11.97%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| May 1, 2026 | Q2 FY2026 | $-2.61 | — | — | — | — |
| Feb 13, 2026 | Q1 FY2026 | $-2.70 | — | — | — | — |
Related Earnings News
Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes
Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift
Novavax Surges on Pfizer Deal, Q1 Revenue Beat Despite Weak Vaccine Sales
Moderna Tops Q1 Revenue Forecast on International Covid Vaccine Sales, Hit by $900M Charge